Karin Frida Ejendal - Publications
Affiliations: | 2006 | Purdue University, West Lafayette, IN, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2007 | Takenaka K, Morgan JA, Scheffer GL, Adachi M, Stewart CF, Sun D, Leggas M, Ejendal KF, Hrycyna CA, Schuetz JD. Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. Cancer Research. 67: 6965-72. PMID 17638908 DOI: 10.1158/0008-5472.Can-06-4720 | 0.742 | |||
2006 | Ejendal KF, Diop NK, Schweiger LC, Hrycyna CA. The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding. Protein Science : a Publication of the Protein Society. 15: 1597-607. PMID 16815914 DOI: 10.1110/Ps.051998406 | 0.396 | |||
2005 | Geisler M, Blakeslee JJ, Bouchard R, Lee OR, Vincenzetti V, Bandyopadhyay A, Titapiwatanakun B, Peer WA, Bailly A, Richards EL, Ejendal KF, Smith AP, Baroux C, Grossniklaus U, Müller A, et al. Cellular efflux of auxin catalyzed by the Arabidopsis MDR/PGP transporter AtPGP1. The Plant Journal : For Cell and Molecular Biology. 44: 179-94. PMID 16212599 DOI: 10.1111/J.1365-313X.2005.02519.X | 0.724 | |||
2005 | Ejendal KF, Hrycyna CA. Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A. Molecular Pharmacology. 67: 902-11. PMID 15598974 DOI: 10.1124/Mol.104.001701 | 0.739 | |||
2002 | Ejendal KF, Hrycyna CA. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Current Protein & Peptide Science. 3: 503-11. PMID 12369998 DOI: 10.2174/1389203023380521 | 0.705 | |||
Show low-probability matches. |